Vivian Cintron, Global Executive Driving Strategies and Innovation*Precision Medicine & Diagnostics*Fractional CXO *Medical Affairs* Business Development*Biomarkers*KOL & Patient Engagements*CHIEF*International Best-Selling Author on Influential Women

Influential Woman · Pharma and biotech

Vivian Cintron

Global Executive Driving Strategies and Innovation*Precision Medicine & Diagnostics*Fractional CXO *Medical Affairs* Business Development*Biomarkers*KOL & Patient Engagements*CHIEF*International Best-Selling Author

Noblesville , IN

Certifications · Degrees · Memberships

Degree PhD in Molecular Biology and Genetics Degree Wayne State University Degree Detroit Degree Michigan Degree Postdoctoral Fellowship in Endocrinology and Protein and Gene Activation Degree National Institutes of Health Degree Postdoctoral Fellowship in Cell Signaling and Molecular Aspects Degree Eli Lilly Pharmaceuticals Degree Internal Care Fellowship Degree Rush Medical Center Member Healthcare Business Women Association (HBA) - Board Member Member Indiana Healthcare Executives - Board Member Member Red Cross Indiana Member Biomed Committee - Member Member Riverview Hospital Indiana - Board Member Member IU Indiana University Healthcare - Board Member Member American College of Executive in Healthcare

Her Story

About Vivian

Since I was a little girl, I was always keen into life science and trying experiments - I would place bread in closets and try to see what was growing on it. That curiosity led me to pursue my PhD in molecular biology and genetics. It was marvelous to see everything from the cell all the way to the human being, and trying to discover what's wrong in terms of diseases and how to attack different pathways to make it more precise in terms of drugs and treatments. After completing my education at Wayne State University and fellowships at the National Institutes of Health and Eli Lilly Pharmaceuticals, I started my first job at Roche Diagnostics, where I spent over 15 years in Medical Affairs working with diagnostic tools and assays for specific disease states. I also served in the United States Army as Reserve Corp, working at the BioThreat laboratory designing tools and diagnostic opportunities for soldiers to pick up any threats in territories. Throughout my career, I've worked with several companies developing strategies for medical affairs and business development. I worked on an alliance between Agilent and Merck, developing strategies globally for Keytruda and diagnostic tools for different indications. Now I run my own consultancy, Vioni Consultants, where I perform professional expertise for strategies for medical affairs, business development, and partnerships. I analyze what's missing for companies, help create and design strategies around those gaps, and guide teams through opportunities. I focus on oncology diseases and rare diseases, working in precision medicine to target specific pharmacos for specific populations. Partnerships are critical in my work - I help smaller companies find partners to make it to production or manufacturing through collaboration contracts. This is a time when pharmas are collaborating more rather than fighting over specific pharmacos, and I help facilitate those partnerships to bring treatments to patients faster.

Her Interview

Ten minutes with Vivian

01What are the biggest challenges or opportunities in your field right now?

I think the biggest opportunity right now is that the loopholes of patents are going away and there are more opportunities to navigate. There are so many societies, alliances, and key experts that can help navigate what is the missing gap and how to make it easier to the patient. When you gather all that information - those insights or evidence - it creates the ability for pharma or biotech to go forward very quickly because there's evidence you can bring in front of the FDA or any world organization. The world is coming smaller where we collaborate more. We don't see the pharmas fighting for a specific pharmaco anymore - now the pharmas are aiming to help or collaborate somehow. The big pharmas are working on the same thing and they can make clauses in contracts to collaborate in certain aspects while continuing other programs. This collaboration in this time, this age, is incredible and we have to take advantage of all that. Companies don't believe anymore in working on something for long, long times. They want something fast, and whoever can produce that, they will collaborate. This is very fast times, and it's exciting because you can bring things really fast, up-to-date, and deliver very fast without the busyness of organization teams.

Join Influential Women and start making an impact. Register now.